# CorePharma, LLC – FDA Inspection, Sep 12, 2024

Source: https://www.keypedia.com/records/fda_inspections/corepharma-llc/debe7cb9-f65c-449a-8bd8-1fa4d1291653
Source feed: FDA_Inspections

> FDA inspection 1240419 of CorePharma, LLC, September 12, 2024. Classification: No Action Indicated (NAI). 13 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240419
- Company Name: CorePharma, LLC
- Inspection Date: 2024-09-12
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1280399 - 2025-08-28](https://www.keypedia.com/records/fda_inspections/corepharma-llc/a79456c1-10bd-4a42-b391-e30e7bd8084c)
- FDA Inspection 1087306 - 2019-03-29
- FDA Inspection 1029942 - 2017-10-13
- FDA Inspection 980585 - 2016-08-11
- FDA Inspection 915404 - 2015-02-24

## Related Officers

- [Investigator](https://www.keypedia.com/people/alisha-b-patel/3c106dac-0e0d-41f2-9f7a-69982d4e6579)
- [Issuing Officer](https://www.keypedia.com/people/rohan-p-sridhar/6918fb94-47b2-4393-a61b-02588bbf1e07)
- [Investigator](https://www.keypedia.com/people/rose-l-jean-mary/398483f5-12f7-429b-8a13-c068b41ff3ed)

Company: https://www.keypedia.com/companies/corepharma-llc/037e485c-5d38-40e3-80fe-b00a72cda489

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
